Log on / register
Feedback | Support | My details
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.
Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER
Cost Eff Resour Alloc 2008, 6:4
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated